Foley & Lardner LLP recently represented Cortical Ventures as an investor in a pre-seed funding round for Kyber Labs, which uses novel artificial muscle technology to enable next-generation robotics manipulation platform. Foley represented Cortical Ventures as the lead investor in the pre-seed funding round.
These new funds will fuel Kyber Labs vision for revolutionizing the robotics industry using their innovative artificial muscle by enabling them to expand their team, accelerate product development, and deeply explore markets where their tech can add the most value.
The Foley team was led by partner Louis Lehot and included associates Saige Gallop and Trevor Mullin.
People
Related News
July 11, 2025
Deals and Wins
Foley Represents Five Elms Capital in $51M Series C Investment in Spacelift
Foley & Lardner LLP represented Five Elms Capital, a software-focused growth equity firm, in its lead investment in the $51 million Series C funding round of Spacelift, an infrastructure orchestration platform that manages the entire infrastructure lifecycle across multi-cloud and hybrid environments.
July 11, 2025
Deals and Wins
Foley Represents Sorcero in Strategic Acquisition of Axiom Health
Foley & Lardner LLP represented Sorcero in its strategic acquisition of Axiom Health, a medtech DaaS (data-as-a-service) company. This marks a pivotal expansion for Sorcero into the medical device market and expands the company’s product suite to include market and product intelligence.
July 10, 2025
Deals and Wins
Foley Represents Verona Pharma in $10B Acquisition by Merck
Foley & Lardner LLP acted as U.S. intellectual property counsel for UK-based Verona Pharma, a biopharmaceutical company focused on respiratory diseases, in its approximately $10 billion acquisition by Merck & Co. Inc. (Merck).